Tyler Jensen, SVP, Engineering and Technology Development at GenMark Diagnostics, Inc. (GNMK), sold 720 shares at $11.34 ($8K) on 2020-10-27, disclosed to the SEC on 2020-10-29.
Scheduled sale ($8k) by SVP, Engineering and Technology Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.34 | 220 | $2K | 30.6% |
| 2 | $11.32 | 500 | $6K | 69.4% |
| Total | $11.33 avg | 720 | $8K | 100% |
| Filing → |
| GNMK | SELL | 2021-02-22 | $11K | — | Filing → |
| GNMK | SELL | 2021-02-16 | $220K | — | Filing → |
| GNMK | SELL | 2021-02-08 | $7K | — | Filing → |